| kathleen 2005-08-25, 8:56 am |
| In case you missed it (below): CDC is fully aware of the fact that
people with different genetic backgrounds will have a different
antibody response.
Klempner and Roland Martin found the Multiple-Sclerosis-like presenting
groups of MHC (major histocompatibility complex).
Only Klempner never published this data. But we have him on audiotape
discussing these findings and now that tape is in the federal court in
Rhode Island and Mr. Blumenthal's office also has a tape, as does the
US Attorney Kevin O'Connor.
That means, the CDC is complicit in these Lyme crimes, because we have
not been told that Lyme arthritis is not the only kind of Lyme.
CDC employees have a contract with SmithKline, and there is no
disputing this conflict of interest.
Now, we can all NOT believe anything else they tell us, particularly
about the safety and efficacy of ANY vaccines.
http://v3.espacenet.com/textdes?DB=...0&QPN=WO9324145
Kathleen
==============
"Table I also shows that the antibody response to a number of the
novel protein antigens derived from B.
burgdorferi strain B31 were MHC restricted. For example, until late in
the infection, only the mouse strain B10 animals respond to the P83
protein. Since mice of the strains B1O.BR and B1O.D2 are perfect
genetic matches except for the MHC locus, apparently, MHC
haplotypesH-2d and H-2k are relatively inefficient at presenting this
protein when compared to H-2b. See, particularly, Examples 10 and 12
below.
As described above for the nonrestricted antigens, these MHC-restricted
antigens are also further characterized by being (a) JD-1 crossreactive
and JD-1
MHC nonrestricted, (b) JD-1 crossreactive and JD-1 MHC restricted, or
(c) JD-1 nonreactive. Although the immune response elicited by these
novel B. burgdorferi antigens is B31MMC restricted, and thus, do not
elicit an immune response in all animal haplotypes, they are also
useful in vaccines to prevent Lyme Disease in humans and other animals
and in diagnostic assays."
|